ÂÜÀòÂÒÂ×

Tim Haggerty is a lab manager and senior scientist at Dana-Farber Cancer Institute, focusing on CART cell therapeutics for Multiple Myeloma. Prior to this, Tim has held positions at various companies such as Draper, FORMA Therapeutics, Inc., Compass Therapeutics, AbbVie, AstraZeneca, CytoCure, LLC, Minerva Biotechnologies, and Johns Hopkins School of Medicine, where Tim has worked on immunology, therapeutic antibody development, cancer cell assay development, and post-doctoral research in hematology and rheumatology. Tim holds a PhD in Molecular and Cellular Biology from Brandeis University and a B.S. in Biology - Molecular Genetics from the University of Rochester.